Medindia LOGIN REGISTER
Medindia
Advertisement

Drugs for Treatment of Graft versus Host Disease (GvHD)

Are you searching for medications to treat 'Graft versus Host Disease (GvHD)'? Welcome to this section, which serves as a repository for medications that are relevant to the treatment of Graft versus Host Disease (GvHD). The page includes both the generic and brand names and can be an invaluable resource for healthcare professionals and individuals who wish to get an insight on different medication options.
Click on a medication below to view details including brand names, prices, dosages, side effects, and administration guidelines.
Additionally, a FAQs section is available for each medication, addressing popular inquiries and providing deeper insights into its use for Graft versus Host Disease (GvHD) management.
We recommend consulting your doctor to verify the information presented on this page or for any additional clarifications.
Advertisement

Brand Names and Generic Names of Drugs for Treatment of Graft versus Host Disease (GvHD)

Daclizumab

Daclizumab is an immunosuppressive agent, prescribed for acute organ rejection during kidney transplantation.
Advertisement

Infliximab

Infliximab is a monoclonal antibody, prescribed for autoimmune disorders, joint pain, Crohn's disease, inflammatory bowel disease, ankylosing spondylitis, psoriasis.
Trade Names :
Advertisement

Pentostatin

Pentostatin is an antineoplastic agent, prescribed for certain types of cancer.



Suggested Readings on Graft versus Host Disease

Low Dose Interleukin-2 can Improve Graft-versus-Host Disease
Low dose interleukin-2 appears to be safe and effective in the treatment of chronic graft-versus-host disease.
'Magic Algorithm' Designed to Identify Graft Versus Host Disease
Scientists identify two key proteins as early markers of graft versus host disease and design magic algorithm for risk identification.
 Novel Treatment to Prevent Graft-Versus-Host-Disease
Graft-versus-host-disease (GVHD) is the leading cause of non-relapse associated death in patients who receive stem cell transplants.
Blood Cancer Drug 'Ibrutinib' Shows Promise For Treating Graft Versus Host Disease
Anticancer drug Ibrutinib shows hope in the treatment of graft versus host disease after stem cell transplantation.
Drugs for Medical Condition A - Z
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
Graft versus Host Disease (GvHD)
Graft versus host disease (GvHD) occurs when donor cells recognize the host cells as foreign and begin to attack it. Symptoms can be mild, severe or even fatal.
Advertisement
Drugs Search

    Advertisement
    What's New on Medindia
    Dental Anesthesia: Your Comprehensive Guide to Painless Dentistry
    Diet After Appendix Surgery
    Know your Appendix Friendly Diet
    View all
    Sponsored Post and Backlink Submission
    Get Health and Wellness Secrets from Our Engaging eBooks
    This site uses cookies to deliver our services.By using our site, you acknowledge that you have read and understand our Cookie Policy, Privacy Policy, and our Terms of Use  Ok, Got it. Close